Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub
Guide6 min read

When Should You Start HRT? The Timing Window, Explained

Why starting HRT near the menopause transition is a different proposition from starting years later, and how to know whether your window is open.

Updated September 8, 2026

Medically reviewed · How we review

Key takeaways

  • When you start HRT shapes the risk-benefit balance - starting near the menopause transition is generally a more favorable proposition than starting many years afterward.
  • The trigger to consider it is symptoms that affect your life, not hitting a particular birthday or a specific lab number.
  • 'I'll tough it out and decide later' is itself a decision with consequences - including that the favorable window doesn't stay open indefinitely.
  • There's no single right age; the right time is individual and best judged with a clinician who knows your history and where you are in the transition.

Is there a 'best time' to start HRT?

There is a widely recognized concept that timing matters, often described as a window: starting HRT around the menopause transition - when symptoms begin - generally carries a more favorable risk-benefit balance than starting for the first time many years after menopause. Much of the fear that attached to HRT in the early 2000s traces to studies that averaged together women starting at very different ages and stages, which muddied exactly this point. The practical upshot is that timing is not a footnote - it is one of the main variables, and it is covered as such in the pros and cons of HRT.

What actually signals it's time to consider it?

Symptoms that are costing you - disrupted sleep from night sweats, hot flashes that interfere with work or life, genitourinary changes, mood and energy shifts tied to the transition. The trigger is impact, not a birthday and not a single hormone reading; menopause is diagnosed clinically far more than by chasing lab numbers, and a good provider treats the woman in front of them rather than a value on a page. If you are unsure whether what you are feeling is even perimenopause yet, perimenopause vs menopause sorts out the stages.

HRT products from top online providers

Real HRT products and published prices from the online providers we rank.

Prescription required: a licensed clinician reviews your health history first. Prices as published in October 2026; confirm at checkout.

What's the risk of waiting?

Two things worth being honest about. First, symptoms you "tough out" are real costs in the meantime - lost sleep, strained work and relationships, and genitourinary changes that tend to worsen rather than pass.

Second, the favorable starting window does not stay open forever; deferring the decision for many years can change the risk-benefit math, so "later" is not a risk-free neutral. This is not a scare tactic - it is the reason clinicians frame waiting as an active choice to discuss rather than a safe default.

So how do I time it right?

Bring it up when symptoms start affecting your life, not when you have endured them long enough to feel you have earned help. Telehealth has removed most of the friction that used to make women wait: Midi and Winona run the evaluation online and can judge, with your history, whether now is a sensible time to start - and our HRT provider comparison maps the field.

If you decide the time is right, how to get HRT online walks the process. This article is general information, not medical advice.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.FDA Approves Labeling Changes to Menopausal Hormone Therapy Products - U.S. Food & Drug Administration - February 2026
  2. 2.FDA Requests Labeling Changes to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies - U.S. Food & Drug Administration - November 2025
  3. 3.The Women's Health Initiative Randomized Trials and Clinical Practice: A Review - Manson JE et al., JAMA - 2024;331(20):1748-1760
  4. 4.The 2022 hormone therapy position statement of The North American Menopause Society - Menopause (journal), The Menopause Society - 2022;29(7):767-794
  5. 5.The 2023 nonhormone therapy position statement of The North American Menopause Society - Menopause (journal), The Menopause Society - 2023
  6. 6.Menopause: identification and management (NG23, updated November 2024) - National Institute for Health and Care Excellence (NICE)
  7. 7.FDA Update on Estradiol Transdermal Patch Availability - U.S. Food & Drug Administration - 2026
  8. 8.Hormone Therapy for Menopause - patient FAQ - American College of Obstetricians and Gynecologists (ACOG)
  9. 9.Menopause - overview - National Institute on Aging (NIA), NIH